Literature DB >> 21131479

Quantification of calsequestrin 2 (CSQ2) in sheep cardiac muscle and Ca2+-binding protein changes in CSQ2 knockout mice.

Robyn M Murphy1, Janelle P Mollica, Nicole A Beard, Bjorn C Knollmann, Graham D Lamb.   

Abstract

Calsequestrin 2 (CSQ2) is generally regarded as the primary Ca2+-buffering molecule present inside the sarcoplasmic reticulum (SR) in cardiac cells, but findings from CSQ2 knockout experiments raise major questions about its role and necessity. This study determined the absolute amount of CSQ2 present in cardiac ventricular muscle to gauge its likely influence on SR free Ca2+ concentration ([Ca2+]) and maximal Ca2+ capacity. Ventricular tissue from hearts of freshly killed sheep was examined by SDS-PAGE without any fractionation, and CSQ2 was detected by Western blotting; this method avoided the >90% loss of CSQ2 occurring with usual fractionation procedures. Band intensities were compared against those for purified CSQ2 run on the same blots. Fidelity of quantification was verified by demonstrating that CSQ2 added to homogenates was detected with equal efficacy as purified CSQ2 alone. Ventricular tissue from sheep (n=8) contained 24±2 μmol CSQ2/kg wet wt. Total Ca2+ content of the ventricular tissue, measured by atomic absorption spectroscopy, was 430±20 μmol/kg (with SR Ca2+ likely<250 μmol/kg) and displayed a linear correlation with CSQ2 content, with gradient of ∼10 Ca2+ per CSQ2. The large amount of CSQ2 bestows the SR with a high theoretical maximal Ca2+-binding capacity (∼1 mmol Ca2+/kg ventricular tissue, assuming a maximum of ∼40 Ca2+ per CSQ2) and would keep free [Ca2+] within the SR relatively low, energetically favoring Ca2+ uptake and reducing SR leak. In mice with CSQ2 ablated, histidine-rich Ca2+-binding protein was upregulated ∼35% in ventricular tissue, possibly in compensation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131479      PMCID: PMC3044055          DOI: 10.1152/ajpheart.00902.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  45 in total

1.  Disruption of excitation-contraction coupling and titin by endogenous Ca2+-activated proteases in toad muscle fibres.

Authors:  Esther Verburg; Robyn M Murphy; D George Stephenson; Graham D Lamb
Journal:  J Physiol       Date:  2005-03-03       Impact factor: 5.182

Review 2.  Cardiac calsequestrin: quest inside the SR.

Authors:  Sandor Györke; Sarah C W Stevens; Dmitry Terentyev
Journal:  J Physiol       Date:  2009-07-01       Impact factor: 5.182

3.  Measurement of SR Ca2+ content in the presence of caffeine in permeabilised rat cardiac trabeculae.

Authors:  G L Smith; D S Steele
Journal:  Pflugers Arch       Date:  1998-12       Impact factor: 3.657

4.  Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia.

Authors:  Björn C Knollmann; Nagesh Chopra; Thinn Hlaing; Brandy Akin; Tao Yang; Kristen Ettensohn; Barbara E C Knollmann; Kenneth D Horton; Neil J Weissman; Izabela Holinstat; Wei Zhang; Dan M Roden; Larry R Jones; Clara Franzini-Armstrong; Karl Pfeifer
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

5.  Histidine-rich Ca binding protein: a regulator of sarcoplasmic reticulum calcium sequestration and cardiac function.

Authors:  Kimberly N Gregory; Kenneth S Ginsburg; Ilona Bodi; Harvey Hahn; Yehia M A Marreez; Qiujing Song; Prabhu A Padmanabhan; Bryan A Mitton; Jason R Waggoner; Federica Del Monte; Woo Jin Park; Gerald W Dorn; Donald M Bers; Evangelia G Kranias
Journal:  J Mol Cell Cardiol       Date:  2006-05       Impact factor: 5.000

6.  Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin.

Authors:  L R Jones; Y J Suzuki; W Wang; Y M Kobayashi; V Ramesh; C Franzini-Armstrong; L Cleemann; M Morad
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

Review 7.  New roles of calsequestrin and triadin in cardiac muscle.

Authors:  Björn C Knollmann
Journal:  J Physiol       Date:  2009-05-18       Impact factor: 5.182

8.  Effect of ADP on slow-twitch muscle fibres of the rat: implications for muscle fatigue.

Authors:  W A Macdonald; D G Stephenson
Journal:  J Physiol       Date:  2006-03-23       Impact factor: 5.182

Review 9.  Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase.

Authors:  Poornima Bhupathy; Gopal J Babu; Muthu Periasamy
Journal:  J Mol Cell Cardiol       Date:  2007-03-12       Impact factor: 5.000

10.  Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.

Authors:  Lei Song; Ronny Alcalai; Michael Arad; Cordula M Wolf; Okan Toka; David A Conner; Charles I Berul; Michael Eldar; Christine E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

View more
  21 in total

1.  Rat skeletal muscle glycogen degradation pathways reveal differential association of glycogen-related proteins with glycogen granules.

Authors:  Hongyang Xu; David Stapleton; Robyn M Murphy
Journal:  J Physiol Biochem       Date:  2015-04-15       Impact factor: 4.158

2.  Important considerations for protein analyses using antibody based techniques: down-sizing Western blotting up-sizes outcomes.

Authors:  Robyn M Murphy; Graham D Lamb
Journal:  J Physiol       Date:  2013-10-14       Impact factor: 5.182

Review 3.  Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia.

Authors:  Michela Faggioni; Dmytro O Kryshtal; Björn C Knollmann
Journal:  Pediatr Cardiol       Date:  2012-03-16       Impact factor: 1.655

4.  Force development and intracellular Ca2+ in intact cardiac muscles from gravin mutant mice.

Authors:  Zhitao Li; Sonal Singh; Santosh V Suryavanshi; Wengang Ding; Xiaoxu Shen; Cori S Wijaya; Wei Dong Gao; Bradley K McConnell
Journal:  Eur J Pharmacol       Date:  2017-04-17       Impact factor: 4.432

Review 5.  Functional interaction between calsequestrin and ryanodine receptor in the heart.

Authors:  Marta Gaburjakova; Naresh C Bal; Jana Gaburjakova; Muthu Periasamy
Journal:  Cell Mol Life Sci       Date:  2012-10-30       Impact factor: 9.261

Review 6.  Calsequestrin 2 and arrhythmias.

Authors:  Michela Faggioni; Björn C Knollmann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-23       Impact factor: 4.733

7.  The C-terminal calcium-sensitive disordered motifs regulate isoform-specific polymerization characteristics of calsequestrin.

Authors:  Naresh C Bal; Nivedita Jena; Harapriya Chakravarty; Amit Kumar; Mei Chi; Tuniki Balaraju; Sharad V Rawale; Jayashree S Rawale; Ashoke Sharon; Muthu Periasamy
Journal:  Biopolymers       Date:  2015-01       Impact factor: 2.505

8.  Control of sarcoplasmic reticulum Ca2+ release by stochastic RyR gating within a 3D model of the cardiac dyad and importance of induction decay for CICR termination.

Authors:  M B Cannell; C H T Kong; M S Imtiaz; D R Laver
Journal:  Biophys J       Date:  2013-05-21       Impact factor: 4.033

9.  Conditional ablation and conditional rescue models for Casq2 elucidate the role of development and of cell-type specific expression of Casq2 in the CPVT2 phenotype.

Authors:  Daniel J Flores; ThuyVy Duong; Luke O Brandenberger; Apratim Mitra; Aditya Shirali; John C Johnson; Danielle Springer; Audrey Noguchi; Zu-Xi Yu; Steven N Ebert; Andreas Ludwig; Bjorn C Knollmann; Mark D Levin; Karl Pfeifer
Journal:  Hum Mol Genet       Date:  2018-05-01       Impact factor: 6.150

Review 10.  Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Matthew J Wleklinski; Prince J Kannankeril; Bjӧrn C Knollmann
Journal:  J Physiol       Date:  2020-04-27       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.